101523-04-0Relevant articles and documents
Solid-Phase Synthesis of the Aged-Nonapeptide-Nerve-Agent Adduct of Butyrylcholinesterase as Reference Materials for Analytical Verification
Bielmann, Andreas,Curty, Christophe,Bochet, Christian G.
, (2017)
Two pathways were developed and investigated for the synthesis of the ‘aged’-nonapeptide nerve-agent bioadduct of human butyrylcholinesterase (BuChE). Considering the fast ageing of nerve-agent adducts of BuChE in patients and biomedical samples this target molecule is of paramount relevance for quantitative analysis with respect to the Chemical Weapons Convention. Two approaches using a precursor bearing a hydroxyl on its phosphonyl moiety and a benzyl protected precursor were considered. Several impurities were identified and circumvented during the optimization of the peptide synthesis step. The ‘aged’-nonapeptide adduct was successfully synthesized by solid-phase-peptide-synthesis (SPPS).
A concise synthesis of α-D-ribofuranosyl alkylphosphonates - Putative substrate intermediates for the carbon-phosphorous lyase system
Luo, Yan,Zechel, David L.
, p. 743 - 747 (2007/10/03)
Carbon-phosphorous lyase is a multienzyme system found in many species of bacteria that is distinguished by its ability to hydrolyze a broad array of unactivated alkylphosphonates. α-D-Ribofuranosyl alkylphosphonates are potential metabolic intermediates
α-haloenamines as reagents for the conversion of phosphorus oxyacids to their halogenated analogues
Norlin, Rikard,Juhlin, Lars,Lind, Per,Trogen, Lars
, p. 1765 - 1770 (2007/10/03)
Phosphorus oxyacids are converted to their halogenated analogues under mild conditions. α-Haloenamines are shown to be effective halogen transfer reagents affording good to high yields of the desired products at reaction times, in some cases, less than one minute. Georg Thieme Verlag Stuttgart.
Phosphorous-containing cysteine and serine protease inhibitors
-
, (2008/06/13)
The present invention is directed to novel phosphorous-containing inhibitors of cysteine or serine proteases. Methods for the use of the protease inhibitors are also described.
SYNTHESIS OF CARBAPENEM-3-PHOSPHONIC ACID DERIVATIVES
Mak, Ching-Pong,Mayerl, Christa,Fliri, Hans
, p. 347 - 350 (2007/10/02)
The synthesis of 6-(1-hydroxyethyl)-2-oxocarbapenem-3-phosphonic acid derivatives, starting from 3-iodomethyl-2-oxoazetidine is described.